Feeds:
Posts
Comments

Search Results for 'TAVR'


Comparison between balloon-expandable (Sapien XT or Sapien 3 valve, Edwards Lifesciences) vs self-expanding (CoreValve, Medtronic) TAVR from 2013 to 2015, Results: Lower mortality rate and other advantages with balloon-expandable valves over self-expanding valves. Reporter: Aviva Lev-Ari, PhD, RN   French Studies Point to Inherent Differences in TAVR Valves FRANCE-TAVI database was funded and managed by the French Society of […]

Read Full Post »


Post TAVR: Management of conduction disturbances and number of valve recapture and/or repositioning attempts – Optimize self-expanding transcatheter aortic valve replacement (TAVR) positioning reduced the need for permanent pacemaker (PPM) implants down the road Reporter: Aviva Lev-Ari, PhD, RN The PPM rate dropped from 9.7% to 3.0% (P=0.035), according to a team led by Hasan […]

Read Full Post »


Are TAVR volume requirements limiting rural and minority access to this life-saving procedure, or are they still necessary for patient safety? Reporter: Aviva Lev-Ari, PhD, RN   CMS Considers Changing TAVR Volume Requirements Debate over transcatheter aortic valve replacement (TAVR) procedures continues as the Centers for Medicare and Medicaid Services (CMS) considers changing the status […]

Read Full Post »


Top 100 of 415 articles published on PubMed in 2018 on TAVR Reporter: Aviva Lev-Ari, PhD, RN   SOURCE https://www.ncbi.nlm.nih.gov/pubmed  %5B2018 TAVR] Select item 301029701. Ninety-Day Readmissions of Bundled Valve Patients: Implications for Healthcare Policy. Koeckert MS, Grossi EA, Vining PF, Abdallah R, Williams MR, Kalkut G, Loulmet DF, Zias EA, Querijero M, Galloway AC. Semin […]

Read Full Post »


Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 9/24/2018 Sapien 3, CoreValve Evolut R on Par for Aortic Stenosis Head-to-head trial also shows local, general anesthesia outcomes similar by Ashley Lyles, Staff Writer, MedPage Today September 23, […]

Read Full Post »


Left ventricular outflow tract (LVOT) obstruction (LVOTO): The Role of CT in TAVR and in TMVR Reporter: Aviva Lev-Ari, PhD, RN   Left ventricular outflow tract obstruction (LVOTO) is a recognised feature of this condition which arises when blood leaving the outflow tract is impeded by systolic anterior motion of the mitral valve. LVOT obstruction was defined as […]

Read Full Post »


Off-Label TAVR Procedures: 1 in 10 associated with higher in-hospital 30-day mortality, 1-year mortality was similar in the Off-Label and the On-Label groups Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 7/10, 2017 FDA clears Medtronic’s CoreValve Evolut TAVR in intermediate risk patients JULY 10, 2017 BY FINK DENSFORD http://www.massdevice.com/fda-clears-medtronics-corevalve-evolut-tavr-in-intermediate-risk-patients/?spMailingID=11443122&spUserID=MTU0MTAzNDg3OTA5S0&spJobID=1200865729&spReportId=MTIwMDg2NTcyOQS2     by Nicole Lou, Reporter, MedPage Today/CRTonline.org June […]

Read Full Post »


First U.S. TAVR Patients Treated With Temporary Pacing Lead (Tempo Lead) Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 8/2/2017 Medtronic wins FDA nod, CE Mark for Avalus aortic valve AUGUST 2, 2017 BY FINK DENSFORD http://www.massdevice.com/medtronic-wins-fda-nod-ce-mark-avalus-aortic-valve/?utm_source=newsletter-170802&utm_medium=email&utm_campaign=newsletter-170802&spMailingID=11611945&spUserID=MTU0MTAzNDg3OTA5S0&spJobID=1220180538&spReportId=MTIyMDE4MDUzOAS2     BioTrace Medical, Inc., a venture backed company based in San Carlos, Calif., is dedicated to reinventing temporary pacing to […]

Read Full Post »


Clinical Trials for Transcatheter Mitral Valves Annulus Repairs and TAVR: CT Structural Software for Procedural Planning and Anatomical Assessments Reporter: Aviva Lev-Ari, PhD, RN     VIEW VIDEO http://www.dicardiology.com/videos/what-look-ct-structural-heart-planning-software/5027704022001?eid=333021707&bid=1497257   What to Look for in CT Structural Heart Planning Software An interview with Jonathan Leipsic, M.D., FSCCT, chairman of the department of radiology, St. Paul’s […]

Read Full Post »


TAVR with Sapien 3: combined all-cause death & disabling stroke rate was 8.4% and 16.6% for the surgery arm Reporter: Aviva Lev-Ari, PhD, RN Edwards Lifesciences hits all-time high on Sapien 3 study APRIL 5, 2016 BY BRAD PERRIELLO LEAVE A COMMENT Shares in Edwards Lifesciences (NYSE:EW) hit an all-time high yesterday after the company reported […]

Read Full Post »

Next »